Bertheuil N, Chaput B, Ménard C, Varin A, Garrido I, Grolleau J L, Sensébé L, Watier E, Tarte K
Service de chirurgie plastique et reconstructrice, université de Rennes 1, hôpital Sud, 16, boulevard de Bulgarie, 35200 Rennes, France; Inserm U917, université de Rennes 1, 35033 Rennes, France; Laboratoire SITI, établissement français du sang Bretagne, CHU de Rennes, 35033 Rennes, France; STROMAlab, UMR5273 CNRS/UPS/EFS, Inserm U1031, hôpital Rangueil, Toulouse, France.
STROMAlab, UMR5273 CNRS/UPS/EFS, Inserm U1031, hôpital Rangueil, Toulouse, France; Service de chirurgie plastique, reconstructrice et esthétique, université Paul-Sabatier, hôpital Rangueil, 31059 Toulouse, France.
Ann Chir Plast Esthet. 2015 Apr;60(2):94-102. doi: 10.1016/j.anplas.2014.09.014. Epub 2014 Oct 29.
Over the last decade, the clinical use of adipose-derived stromal/stem cells (ASC) in regenerative medicine is rapidly increasing. ASC belong to the mesenchymal stromal cells initially obtained from the bone marrow. Their limited differentiation capacity in vivo into functional mature cells has led to a reassessment of their mechanisms of action. One of the major clinical interests appears related to paracrine effects through a temporary production of trophic and immunomodulatory factors. Our purpose is to provide a review on the latest knowledge in the field of ASC, mechanisms of action, mainly immunomodulatory/immunosuppressive properties, methods of obtention, with a focus on clinical perspectives particularly in the field of cellular therapy and fat grafting technique in plastic surgery.
在过去十年中,脂肪来源的基质/干细胞(ASC)在再生医学中的临床应用正在迅速增加。ASC属于最初从骨髓中获得的间充质基质细胞。它们在体内向功能性成熟细胞的分化能力有限,这导致了对其作用机制的重新评估。主要的临床兴趣之一似乎与通过暂时产生营养和免疫调节因子的旁分泌作用有关。我们的目的是对ASC领域的最新知识、作用机制(主要是免疫调节/免疫抑制特性)、获取方法进行综述,重点关注临床前景,特别是在细胞治疗和整形外科脂肪移植技术领域。